Eris Lifesciences Limited (NSE:ERIS)
1,360.70
-9.50 (-0.69%)
At close: Mar 6, 2026
Eris Lifesciences Employees
Eris Lifesciences had 3,354 employees as of March 31, 2025. The number of employees decreased by 266 or -7.35% compared to the previous year.
Employees
3,354
Change (1Y)
-266
Growth (1Y)
-7.35%
Revenue / Employee
9.14M INR
Profits / Employee
1.29M INR
Market Cap
188.49B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 3,354 | -266 | -7.35% |
| Mar 31, 2024 | 3,620 | 939 | 35.02% |
| Mar 31, 2023 | 2,681 | -719 | -21.15% |
| Mar 31, 2022 | 3,400 | 154 | 4.74% |
| Mar 31, 2021 | 3,246 | -184 | -5.36% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ipca Laboratories | 16,778 |
| Alembic Pharmaceuticals | 16,571 |
| Ajanta Pharma | 9,628 |
| Emcure Pharmaceuticals | 6,731 |
| Piramal Pharma | 5,476 |
| Gland Pharma | 4,351 |
| NATCO Pharma | 4,199 |
| Strides Pharma Science | 3,301 |
Eris Lifesciences News
- 12 days ago - Eris Lifesciences partners with Natco Pharma to launch Semaglutide in India - Business Upturn
- 22 days ago - Eris Lifesciences Ltd (NSE:ERIS) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amid ... - GuruFocus
- 22 days ago - Q3 2026 Eris Lifesciences Ltd Earnings Call Transcript - GuruFocus
- 23 days ago - Eris Lifesciences Q3 Results: Revenue jumps 10% YoY to Rs 807 crore, net profit up 19% - Business Upturn
- 4 months ago - Eris Lifesciences Ltd (NSE:ERIS) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 4 months ago - Q2 2026 Eris Lifesciences Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - Eris Lifesciences Q2 Results: Net profit jumps 31% YoY to Rs 120 crore, revenue up 6.3% - Business Upturn
- 6 months ago - Eris Lifesciences secures ANVISA approval for Ahmedabad sterile injectable facility - Business Upturn